Detalles de la búsqueda
1.
Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.
J Infect Dis
; 228(7): 919-925, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526315
2.
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
HIV Med
; 24(6): 727-737, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810955
3.
Impact of time of culture specimen collection on the recovery of Neisseria gonorrhoeae after a positive nucleic acid amplification test.
Sex Transm Infect
; 99(8): 520-526, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802652
4.
Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS.
Dis Colon Rectum
; 66(12): e1186-e1194, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37556018
5.
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease.
J Antimicrob Chemother
; 77(7): 1989-1991, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35425985
6.
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations.
PLoS Pathog
; 15(8): e1007991, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31425551
7.
Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services.
HIV Med
; 22(10): 944-957, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432363
8.
Screening for asymptomatic STIs in HIV-infected men who have sex with men.
Sex Transm Infect
; 97(2): 170-171, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32753480
9.
Digital technology for anaphylaxis management impact on patient behaviour: A randomized clinical trial.
Allergy
; 76(5): 1507-1516, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33043475
10.
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice.
J Antimicrob Chemother
; 74(6): 1693-1700, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838386
11.
Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016.
Euro Surveill
; 24(7)2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30782268
12.
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
J Antimicrob Chemother
; 73(3): 732-737, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29237008
13.
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Clin Infect Dis
; 65(12): 2112-2118, 2017 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020293
14.
Effectiveness and safety of an abacavir/lamivudineâ+ârilpivirine regimen for the treatment of HIV-1 infection in naive patients.
J Antimicrob Chemother
; 71(12): 3510-3514, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27591292
15.
The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial.
Clin Infect Dis
; 61(3): 403-8, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25870325
16.
Darunavir and ritonavir total and unbound plasmatic concentrations in HIV-HCV-coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients.
Antimicrob Agents Chemother
; 59(11): 6782-90, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26282411
17.
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial.
J Antimicrob Chemother
; 70(4): 1139-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25525195
18.
Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.
J Antimicrob Chemother
; 70(5): 1513-6, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25608583
19.
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.
J Antimicrob Chemother
; 69(5): 1390-6, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24415645
20.
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial.
Lancet HIV
; 11(3): e156-e166, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38417976